The FDA’s Oncologic Drugs Advisory Committee recently voted to narrow the label for checkpoint inhibitors Keytruda and Opdivo ...
This review discusses the current state of multicancer early detection tests, the role of machine learning in their ...
Mainz Biomed (MYNZ) announced it has entered into a License and Option Agreement with Liquid Biosciences to access a portfolio of novel mRNA ...
AZoLifeSciences on MSN1d
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic CancerMainz Biomed N.V. (“Mainz Biomed”) , a molecular genetics diagnostic company specializing in the early detection of cancer, ...
Dr. Park shares the three biggest takeaways, in his opinion, to have come out of the ASCO GU Symposium, highlighting studies ...
Advancements in precision medicine: Identifying biomarkers for tailored treatment Personalized medicine focuses on individualized treatment, with the identification of biomarkers – biological ...
It was able to have its drug achieve compelling biomarker and functional data from the ongoing phase 1/2 ACHIEVE trial targeting this specific group of patients in May of 2024. With this clinical ...
A molecule called glial fibrillary acidic protein (GFAP) rose significantly in the blood of patients who underwent ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback